NCT05316181 2026-02-12
KOV-HIPEC-02R
National Cancer Center, Korea
Phase 3 Active not recruiting
National Cancer Center, Korea
Azienda USL Reggio Emilia - IRCCS
Shanghai Gynecologic Oncology Group
Sorlandet Hospital HF
Turku University Hospital
EDDC (Experimental Drug Development Centre), A*STAR Research Entities